Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denise M Wolf

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Frontiers in Oncology|June 29, 2023
Computational drug repositioning for the identification of new agents to sensitize drug-resistant breast tumors across treatments and receptor subtypesKatharine Yu, Amrita Basu, Christina Yau, et al.
JCO Precision Oncology|September 22, 2023
Characterization of the Tumor Microenvironment of De Novo Oligometastatic Breast Cancer in a Nationwide CohortTessa G Steenbruggen, Denise M Wolf, Bram Thijssen, et al.
Breast Cancer Research and Treatment|April 7, 2023
Association of baseline ROR1 and ROR2 gene expression with clinical outcomes in the I-SPY2 neoadjuvant breast cancer trialBarbara A Parker, Rebecca A Shatsky, Richard B Schwab, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2024
Hormone Receptor-Positive HER2-Negative/MammaPrint High-2 Breast Cancers Closely Resemble Triple-Negative Breast CancersAlejandro Rios-Hoyo, Kaitlyn Xiong, Jiawei Dai, et al.
Breast Cancer Research and Treatment|September 4, 2012
Xenografts faithfully recapitulate breast cancer-specific gene expression patterns of parent primary breast tumorsLaura A Petrillo, Denise M Wolf, Ann M Kapoun, et al.
NPJ Breast Cancer|October 21, 2020
Mechanism of action biomarkers predicting response to AKT inhibition in the I-SPY 2 breast cancer trialDenise M Wolf, Christina Yau, Julia Wulfkuhle, et al.
Breast Cancer Research and Treatment|November 30, 2014
Expression profiling of circulating tumor cells in metastatic breast cancerJulie E Lang, Janet H Scott, Denise M Wolf, et al.
Cell|April 7, 2018
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome AnalyticsJianfang Liu, Tara Lichtenberg, Katherine A Hoadley, et al.
Cancer Cell|September 13, 2017
Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell ImmunityMiranda L Broz, Mikhail Binnewies, Bijan Boldajipour, et al.
Cancer Cell|December 3, 2014
Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunityMiranda L Broz, Mikhail Binnewies, Bijan Boldajipour, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Frontiers in Oncology|June 29, 2023
Computational drug repositioning for the identification of new agents to sensitize drug-resistant breast tumors across treatments and receptor subtypesKatharine Yu, Amrita Basu, Christina Yau, et al.
JCO Precision Oncology|September 22, 2023
Characterization of the Tumor Microenvironment of De Novo Oligometastatic Breast Cancer in a Nationwide CohortTessa G Steenbruggen, Denise M Wolf, Bram Thijssen, et al.
Breast Cancer Research and Treatment|April 7, 2023
Association of baseline ROR1 and ROR2 gene expression with clinical outcomes in the I-SPY2 neoadjuvant breast cancer trialBarbara A Parker, Rebecca A Shatsky, Richard B Schwab, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2024
Hormone Receptor-Positive HER2-Negative/MammaPrint High-2 Breast Cancers Closely Resemble Triple-Negative Breast CancersAlejandro Rios-Hoyo, Kaitlyn Xiong, Jiawei Dai, et al.
Breast Cancer Research and Treatment|September 4, 2012
Xenografts faithfully recapitulate breast cancer-specific gene expression patterns of parent primary breast tumorsLaura A Petrillo, Denise M Wolf, Ann M Kapoun, et al.
NPJ Breast Cancer|October 21, 2020
Mechanism of action biomarkers predicting response to AKT inhibition in the I-SPY 2 breast cancer trialDenise M Wolf, Christina Yau, Julia Wulfkuhle, et al.
Breast Cancer Research and Treatment|November 30, 2014
Expression profiling of circulating tumor cells in metastatic breast cancerJulie E Lang, Janet H Scott, Denise M Wolf, et al.
Cell|April 7, 2018
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome AnalyticsJianfang Liu, Tara Lichtenberg, Katherine A Hoadley, et al.
Cancer Cell|September 13, 2017
Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell ImmunityMiranda L Broz, Mikhail Binnewies, Bijan Boldajipour, et al.
Cancer Cell|December 3, 2014
Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunityMiranda L Broz, Mikhail Binnewies, Bijan Boldajipour, et al.
Pageof 7